ArticleTranslational cancer research2019
Alpha-actinin 4 and tumorigenesis of hepatocellular carcinoma.
Article in Translational cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Exploring the potential role of palladin in modulating human CAF/ECM functional units.Cytoskeleton (Hoboken, N.J.) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe examined the expression of alpha-actinin 4 (ACTN4) in hepatocellular carcinoma (HCC) tissues, to investigate the relationships between the expression of ACTN4 and the clinicopathological features of HCC patients. We have also analyzed the relevance of ACTN4 expression and survival time after HCC patients undergo surgery.
methodsThe expression of ACTN4 was analyzed by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunohistochemistry in 87 HCC patients. Statistical analyses were conducted with SPSS 22.0 software.
resultsqRT-PCR revealed that the expression of ACTN4 mRNA was significantly higher in HCC tissues than in adjacent tissues. Immunohistochemistry revealed that the positivity rate of ACTN4 was increased in HCC tissues compared with adjacent tissues (P=0.029). A Mann-Whitney U analysis revealed that positive ACNT4 expression was statistically significantly associated with the lymph node statuses of the HCC patients. Kaplan-Meier curves revealed that positive ACTN4 expression was inversely correlated with the 5-year survival times of HCC patients after surgery, and this relationship was statistically significant.
conclusionsACTN4 plays an important role in the carcinogenesis and progression of HCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.